A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis
暂无分享,去创建一个
Marco Rovaris | Enzo Grossi | Raffaello Nemni | Mario Clerici | Maira Gironi | M. Rovaris | R. Nemni | E. Grossi | M. Vaghi | M. Saresella | Marina Saresella | Matilde Vaghi | M. Gironi | M. Clerici
[1] H. Hartung,et al. Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis , 2005, The Lancet Neurology.
[2] C. Caruso. Immunity & Ageing , 2009 .
[3] M. Filippi,et al. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease , 2001, Journal of Neuroimmunology.
[4] Paolo Massimo Buscema,et al. The semantic connectivity map: an adapting self-organising knowledge discovery method in data bases. Experience in gastro-oesophageal reflux disease , 2008, Int. J. Data Min. Bioinform..
[5] M. Clerici,et al. Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. , 1998, Journal of immunology.
[6] M. Rovaris,et al. Immunological patterns identifying disease course and evolution in multiple sclerosis patients , 2005, Journal of Neuroimmunology.
[7] Paolo Massimo Buscema,et al. The IFAST model, a novel parallel nonlinear EEG analysis technique, distinguishes mild cognitive impairment and Alzheimer's disease patients with high degree of accuracy , 2007, Artif. Intell. Medicine.
[8] V. Kuchroo,et al. IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells , 2008, Nature Immunology.
[9] T. Mcclanahan,et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract , 2006, The Journal of experimental medicine.
[10] A. Thompson,et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.
[11] David C. Snowdon,et al. Auto-Contractive Maps: an artificial adaptive system for data mining. An application to Alzheimer disease. , 2008, Current Alzheimer research.
[12] M Rovaris,et al. MRI features of benign multiple sclerosis , 2009, Neurology.
[13] D. J. Matthews,et al. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. , 2000, Immunity.
[14] B. Becher,et al. IL-9 as a mediator of Th17-driven inflammatory disease , 2009, The Journal of experimental medicine.
[15] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[16] B. Castellano,et al. Increase in Th17 and T-reg Lymphocytes and Decrease of IL22 Correlate with the Recovery Phase of Acute EAE IN Rat , 2011, PloS one.
[17] M. Clerici,et al. CD4+CD25+FoxP3+PD1— regulatory T cells in acute and stable relapsing‐remitting multiple sclerosis and their modulation by therapy , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] T. Wynn,et al. Regulation and Function of the Interleukin 13 Receptor α 2 During a T Helper Cell Type 2–dominant Immune Response , 2003, The Journal of experimental medicine.
[19] A. Thompson,et al. Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis , 2004, Multiple sclerosis.
[20] B. Becher,et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis , 2005, Nature Medicine.
[21] F. Paul,et al. Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica , 2007, PLoS medicine.
[22] M. Buscema. Auto-Contractive Maps, H Function and Maximally Regular Graph - Theory , 2009 .
[23] M. Leach,et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.